Clinical Scorecard: PFAS: New Frontiers, Emerging Solutions

At a Glance

Key Highlights

• PFAS are known as 'forever chemicals' due to their persistence in the environment.
• Analytical methods for detecting PFAS have evolved significantly, particularly with the use of LC-MS.
• Long-chain PFASs are more problematic and have established bioaccumulation and toxicity.
• Short-chain and ultra-short PFASs present different challenges and concerns.
• Current analytical challenges include identifying all relevant PFAS compounds.

Guideline-Based Recommendations

Diagnosis

• Monitor exposure levels in populations at risk.

Management

• Implement strategies for reducing PFAS exposure in affected communities.

Monitoring & Follow-up

• Utilize advanced analytical techniques like high-resolution LC-MS for environmental samples.

Risks

• Consider the health impacts associated with long-chain PFAS exposure.

Patient & Prescribing Data

Individuals in contaminated areas or using products containing PFAS.

Focus on reducing exposure and monitoring health effects.

Clinical Best Practices

• Stay updated on evolving analytical methods for PFAS detection.
• Engage in interdisciplinary research to address PFAS challenges.
• Advocate for regulatory measures to limit PFAS use and exposure.

References

• PFAS Research Overview